Bile acid metabolism and signaling, the microbiota, and metabolic disease
Open accessThe DOI matches its Crossref record; 399 of the 399 references it cites were found in a registry or an index.
Abstract
The diversity, composition, and function of the microbial community inhabiting the human gastrointestinal tract contributes to host health through its role in producing energy or signaling molecules that regulate metabolic and immunologic functions. Bile acids are potent metabolic and immune signaling molecules synthesized from cholesterol in the liver and then transported to the intestine where they can undergo metabolism by gut bacteria. The combination of host- and microbiota-derived enzymatic activities contribute to the composition of the bile acid pool and thus there can be great diversity in bile acid composition that depends in part on the differences in the gut bacteria species. Bile acids can profoundly impact host metabolic and immunological functions by activating different bile acid receptors to regulate signaling pathways that control a broad range of complex symbiotic metabolic networks, including glucose, lipid, steroid and xenobiotic metabolism, and modulation of energy homeostasis. Disruption of bile acid signaling due to perturbation of the gut microbiota or dysregulation of the gut microbiota-host interaction is associated with the pathogenesis and progression of metabolic disorders. The metabolic and immunological roles of bile acids in human health have led to novel therapeutic approaches to manipulate the bile acid pool size, composition, and function by targeting one or multiple components of the microbiota-bile acid-bile acid activated receptor axis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–399 of 399
Catry, E., Bindels, L. B., Tailleux, A., Lestavel, S., Neyrinck, A. M., Goossens, J.-F., Lobysheva, I., Plovier, H., Essaghir, A., Demoulin, J.-B., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-313316 · Cited by 194
Kowdley, K. V., Vuppalanchi, R., Levy, C., Floreani, A., Andreone, P., LaRusso, N. F., Shrestha, R., Trotter, J., Goldberg, D., Rushbrook, S., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.02.033 · Cited by 192
The bile acid sensor FXR regulates insulin transcription and secretion
Renga, B., Mencarelli, A., Vavassori, P., Brancaleone, V., & Fiorucci, S. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.01.002 · Cited by 189
Kitahara, M., Takamine, F., Imamura, T., & Benno, Y. (2001) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/00207713-51-1-39 · Cited by 189
Lithocholic Acid Feeding Induces Segmental Bile Duct Obstruction and Destructive Cholangitis in Mice
Fickert, P., Fuchsbichler, A., Marschall, H.-U., Wagner, M., Zollner, G., Krause, R., Zatloukal, K., Jaeschke, H., Denk, H., & Trauner, M. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050404 · Cited by 188
Pai, R., Tarnawski, A. S., & Tran, T. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-12-0894 · Cited by 182
TGR5 potentiates GLP-1 secretion in response to anionic exchange resins
Harach, T., Pols, T. W. H., Nomura, M., Maida, A., Watanabe, M., Auwerx, J., & Schoonjans, K. (2012) · Scientific Reports · doi:10.1038/srep00430 · Cited by 179
Non-alcoholic fatty liver disease in 2015
Ahmed, M. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i11.1450 · Cited by 175
Chemistry and Enterohepatic Circulation of Bile Acids† ‡ § ¶ # ‖ ** †† ‡‡ §§ ¶¶ ‖‖ ##
Hofmann, A. F. (1984) · Hepatology · doi:10.1002/hep.1840040803 · Cited by 175
Gnerre, C., Bl??ttler, S., Kaufmann, M. R., Looser, R., & Meyer, U. A. (2004) · Pharmacogenetics · doi:10.1097/00008571-200410000-00001 · Cited by 173
Xu, Y., Li, F., Zalzala, M., Xu, J., Gonzalez, F. J., Adorini, L., Lee, Y., Yin, L., & Zhang, Y. (2016) · Hepatology · doi:10.1002/hep.28712 · Cited by 172
Jung, D., Podvinec, M., Meyer, U. A., Mangelsdorf, D. J., Fried, M., Meier, P. J., & Kullak–Ublick, G. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.33583 · Cited by 170
Lucas, L. N., Barrett, K., Kerby, R. L., Zhang, Q., Cattaneo, L. E., Stevenson, D., Rey, F. E., & Amador-Noguez, D. (2021) · mSystems · doi:10.1128/msystems.00805-21 · Cited by 168
Lactobacilli and bile salt hydrolase in the murine intestinal tract
Tannock, G. W., Dashkevicz, M. P., & Feighner, S. D. (1989) · Applied and Environmental Microbiology · doi:10.1128/aem.55.7.1848-1851.1989 · Cited by 166
Interactions between Diet, Bile Acid Metabolism, Gut Microbiota, and Inflammatory Bowel Diseases
Devkota, S., & Chang, E. B. (2015) · Digestive Diseases · doi:10.1159/000371687 · Cited by 166
Synthetic FXR Agonist GW4064 Prevents Diet-Induced Hepatic Steatosis and Insulin Resistance
Ma, Y., Huang, Y., Yan, L., Gao, M., & Liu, D. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-0986-7 · Cited by 165
Bile Salt–Induced Apoptosis Involves NADPH Oxidase Isoform Activation
Reinehr, R., Becker, S., Keitel, V., Eberle, A., Grether‐Beck, S., & Häussinger, D. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.023 · Cited by 164
Hyocholic acid species as novel biomarkers for metabolic disorders
Zheng, X., Chen, T., Zhao, A., Ning, Z., Kuang, J., Wang, S., You, Y., Bao, Y., Ma, X., Yu, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21744-w · Cited by 163
Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects
Chaudhari, S. N., Harris, D. A., Aliakbarian, H., Luo, J. N., Henke, M. T., Subramaniam, R., Vernon, A. H., Tavakkoli, A., Sheu, E. G., & Devlin, A. S. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0604-z · Cited by 160
Intestinal Bile Acid Transport: Biology, Physiology, and Pathophysiology
Shneider, B. L. (2001) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2001.tb07287.x · Cited by 159
Echchgadda, I., Song, C. S., Roy, A. K., & Chatterjee, B. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.720 · Cited by 156
Perfusion of the Canine Colon with Unconjugated Bile Acids
Mekhjian, H. S., & Phillips, S. F. (1970) · Gastroenterology · doi:10.1016/s0016-5085(19)33798-9 · Cited by 154
Im, E., & Martinez, J. D. (2004) · Journal of Nutrition · doi:10.1093/jn/134.2.483 · Cited by 154
Bile Acids and the Membrane Bile Acid Receptor TGR5—Connecting Nutrition and Metabolism
Thomas, C., Auwerx, J., & Schoonjans, K. (2008) · Thyroid · doi:10.1089/thy.2007.0255 · Cited by 154
Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice
Potthoff, M. J., Potts, A., He, T., Duarte, J. A. G., Taussig, R., Mangelsdorf, D. J., Kliewer, S. A., & Burgess, S. C. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00400.2012 · Cited by 154
Zhou, M., Learned, R. M., Rossi, S. J., DePaoli, A. M., Tian, H., & Ling, L. (2017) · Hepatology Communications · doi:10.1002/hep4.1108 · Cited by 152
Lee, Y.-K., Schmidt, D. R., Cummins, C. L., Choi, M., Peng, L., Zhang, Y., Goodwin, B., Hammer, R. E., Mangelsdorf, D. J., & Kliewer, S. A. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0565 · Cited by 151
Caron, S., Huaman Samanez, C., Dehondt, H., Ploton, M., Briand, O., Lien, F., Dorchies, E., Dumont, J., Postic, C., Cariou, B., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01004-12 · Cited by 150
Winston, J. A., & Theriot, C. M. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.05.003 · Cited by 150
Hydroxysteroid dehydrogenases (HSDs) in bacteria – A bioinformatic perspective
Kisiela, M., Skarka, A., Ebert, B., & Maser, E. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.08.002 · Cited by 148
Central anorexigenic actions of bile acids are mediated by TGR5
Perino, A., Velázquez-Villegas, L. A., Bresciani, N., Sun, Y., Huang, Q., Fénelon, V. S., Castellanos-Jankiewicz, A., Zizzari, P., Bruschetta, G., Jin, S., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00398-4 · Cited by 148
Role of Fat Hydrolysis in Regulating Glucagon-Like Peptide-1 Secretion
Beglinger, S., Drewe, J., Schirra, J., Göke, B., D'Amato, M., & Beglinger, C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1062 · Cited by 146
Purification and characterization of bile salt hydrolase from Bacteroides fragilis subsp. fragilis
Stellwag, E. J., & Hylemon, P. B. (1976) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(76)90068-1 · Cited by 145
Sex differences in lipid metabolism are affected by presence of the gut microbiota
Baars, A., Oosting, A., Lohuis, M. A. M., Koehorst, M., Aidy, S. E., Hugenholtz, F., Smidt, H., Mischke, M., Boekschoten, M. V., Verkade, H. J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31695-w · Cited by 143
Wu, Q., Sun, L., Hu, X., Wang, X., Xu, F., Chen, B., Liang, X., Xia, J., Wang, P., Aibara, D., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142865 · Cited by 142
Self-citationMiethke, A. G., Zhang, W., Simmons, J., Taylor, A. E., Shi, T., Shanmukhappa, S. K., Karns, R., White, S., Jegga, A. G., Lages, C. S., et al. (2016) · Hepatology · doi:10.1002/hep.27973 · Cited by 141
Cloning and characterization of a conjugated bile acid hydrolase gene from Clostridium perfringens
Coleman, J. P., & Hudson, L. L. (1995) · Applied and Environmental Microbiology · doi:10.1128/aem.61.7.2514-2520.1995 · Cited by 140
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2010) · Anaerobe · doi:10.1016/j.anaerobe.2009.05.004 · Cited by 138
Bernstein, H. (1999) · Toxicology Letters · doi:10.1016/s0378-4274(99)00113-7 · Cited by 138
Deconjugation of Bile Acids by Intestinal Bacteria: Review of Literature and Additional Studies
Shimada, K., Bricknell, K. S., & Finegold, S. M. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.273 · Cited by 138
A Novel Bile Acid-Activated Vitamin D Receptor Signaling in Human Hepatocytes
Han, S., Li, T., Ellis, E., Strom, S., & Chiang, J. Y. L. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0482 · Cited by 137
Self-citationKodama, S., Moore, R., Yamamoto, Y., & Negishi, M. (2007) · Biochemical Journal · doi:10.1042/bj20070481 · Cited by 136
Ðanić, M., Stanimirov, B., Pavlović, N., Goločorbin-Kon, S., Al-Salami, H., Stankov, K., & Mikov, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01382 · Cited by 133
PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine
Li, T., Chen, W., & Chiang, J. Y. L. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600282-jlr200 · Cited by 132
Self-citationFXR Agonists as Therapeutic Agents for Non-alcoholic Fatty Liver Disease
Carr, R. M., & Reid, A. E. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0500-2 · Cited by 132
Zhang, F., Yu, L., Lin, X., Cheng, P., He, L., Li, X., Lu, X., Tan, Y., Yang, H., Cai, L., et al. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1155 · Cited by 130
Transport and biological activities of bile acids
Zwicker, B. L., & Agellon, L. B. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.04.012 · Cited by 130
Alterations of Hormonally Active Fibroblast Growth Factors after Roux-en-Y Gastric Bypass Surgery
Jansen, P. L. M., van Werven, J., Aarts, E., Berends, F., Janssen, I., Stoker, J., & Schaap, F. G. (2011) · Digestive Diseases · doi:10.1159/000324128 · Cited by 130
Probiotics—Interactions with Bile Acids and Impact on Cholesterol Metabolism
Pavlović, N., Stankov, K., & Mikov, M. (2012) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-012-9904-4 · Cited by 130
Harrison, S. A., Bashir, M. R., Lee, K.-J., Shim-Lopez, J., Lee, J., Wagner, B., Smith, N. D., Chen, H. C., & Lawitz, E. J. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.047 · Cited by 130
Yasuda, H., Hirata, S., Inoue, K., Mashima, H., Ohnishi, H., & Yoshiba, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.168 · Cited by 126
Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism
Zhang, L., Xie, C., Nichols, R. G., Chan, S. H. J., Jiang, C., Hao, R., Smith, P. B., Cai, J., Simons, M. N., Hatzakis, E., et al. (2016) · mSystems · doi:10.1128/msystems.00070-16 · Cited by 126
Self-citationKumar, R., Grover, S., & Batish, V. K. (2012) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-012-9101-3 · Cited by 123
Perides, G., Laukkarinen, J. M., Vassileva, G., & Steer, M. L. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.10.052 · Cited by 123
Completion of the gut microbial epi-bile acid pathway
Doden, H. L., Wolf, P. G., Gaskins, H. R., Anantharaman, K., Alves, J. M. P., & Ridlon, J. M. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1907271 · Cited by 123
The effects of probiotics on total cholesterol: A meta-analysis of randomized controlled trials
Wang, L., Guo, M.-J., Gao, Q., Yang, J.-F., Yang, L., Pang, X.-L., & Jiang, X.-J. (2018) · Medicine · doi:10.1097/md.0000000000009679 · Cited by 122
Straniero, S., Laskar, A., Savva, C., Härdfeldt, J., Angelin, B., & Rudling, M. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000307 · Cited by 121
Han, S., & Chiang, J. Y. L. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.025155 · Cited by 120
Self-citationFranz, C. M. A. P., Specht, I., Haberer, P., & Holzapfel, W. H. (2001) · Journal of Food Protection · doi:10.4315/0362-028x-64.5.725 · Cited by 118
Doden, H., Sallam, L. A., Devendran, S., Ly, L., Doden, G., Daniel, S. L., Alves, J. M. P., & Ridlon, J. M. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.00235-18 · Cited by 118
Gut microbiota inhibit Asbt-dependent intestinal bile acid reabsorption via Gata4
Out, C., Patankar, J. V., Doktorova, M., Boesjes, M., Bos, T., de Boer, S., Havinga, R., Wolters, H., Boverhof, R., van Dijk, T. H., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.030 · Cited by 117
Obeticholic Acid: First Global Approval
Markham, A., & Keam, S. J. (2016) · Drugs · doi:10.1007/s40265-016-0616-x · Cited by 117
Early Growth Response Factor-1 Is Critical for Cholestatic Liver Injury
Kim, N. D., Moon, J.-O., Slitt, A. L., & Copple, B. L. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj111 · Cited by 114
Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis
CHIANELLI, D., Rucker, P. V., Roland, J. T., Tully, D. C., Nelson, J. T., Liu, X., Bursulaya, B. D., Hernandez, E. D., Wu, J., Prashad, M., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01621 · Cited by 114
Farnesoid X receptor represses hepatic human APOA gene expression
Chennamsetty, I., Claudel, T., Kostner, K. M., Baghdasaryan, A., Kratky, D., Levak-Frank, S., Frank, S., Gonzalez, F. J., Trauner, M., & Kostner, G. M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45277 · Cited by 112
Cariello, M., Piccinin, E., García‐Irigoyen, O., Sabbà, C., & Moschetta, A. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.09.019 · Cited by 112
Bile acid homeostasis in female mice deficient in Cyp7a1 and Cyp27a1
Rizzolo, D., Kong, B., Taylor, R. E., Brinker, A., Goedken, M. J., Buckley, B., & Guo, G. L. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.023 · Cited by 112
Degradation of steroids by intestinal bacteria
Goddard, P., & Hill, M. J. (1972) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(72)90101-4 · Cited by 111
Nuclear Receptor Control of Enterohepatic Circulation
Gonzalez, F. J. (2012) · Comprehensive physiology · doi:10.1002/cphy.c120007 · Cited by 110
Novel biotransformation and physiological properties of norursodeoxycholic acid in humans†‡
Hofmann, A. F., Zakko, S. F., Lira, M., Clerici, C., Hagey, L. R., Lambert, K. K., Steinbach, J. H., Schteingart, C. D., Olinga, P., & Groothuis, G. M. M. (2005) · Hepatology · doi:10.1002/hep.20943 · Cited by 110
Review article: bile acid diarrhoea – pathogenesis, diagnosis and management
Mottacki, N., Simrén, M., & Bajor, A. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13570 · Cited by 110
The farnesoid X receptor induces very low density lipoprotein receptor gene expression
Sirvent, A., Claudel, T., Martin, G., Brozek, J., Kosykh, V., Darteil, R., Hum, D. W., Fruchart, J.-C., & Staels, B. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.04.026 · Cited by 109
Fletcher, J. R., Erwin, S., Lanzas, C., & Theriot, C. M. (2018) · mSphere · doi:10.1128/msphere.00089-18 · Cited by 106
Grill, J., Schneider, F., Crociani, J., & Ballongue, J. (1995) · Applied and Environmental Microbiology · doi:10.1128/aem.61.7.2577-2582.1995 · Cited by 105
Doerner, K. C., Takamine, F., LaVoie, C. P., Mallonee, D. H., & Hylemon, P. B. (1997) · Applied and Environmental Microbiology · doi:10.1128/aem.63.3.1185-1188.1997 · Cited by 105
RORγt, a multitask nuclear receptor at mucosal surfaces
Eberl, G. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.86 · Cited by 105
Cloning and sequencing of a bile acid-inducible operon from Eubacterium sp. strain VPI 12708
Mallonee, D. H., White, W. B., & Hylemon, P. B. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.12.7011-7019.1990 · Cited by 102
Winston, J. A., Rivera, A. J., Cai, J., Thanissery, R., Montgomery, S. A., Patterson, A. D., & Theriot, C. M. (2020) · Infection and Immunity · doi:10.1128/iai.00045-20 · Cited by 102
Self-citationLithocholic acid can carry out in vivo functions of vitamin D
Nehring, J. A., Zierold, C., & DeLuca, H. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703512104 · Cited by 99
Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE−/− mice by SC-435
Bhat, B. G., Rapp, S. R., Beaudry, J. A., Napawan, N., Butteiger, D. N., Hall, K. A., Null, C. L., Luo, Y., & Keller, B. T. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200469-jlr200 · Cited by 99
Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice
Matsubara, T., Tanaka, N., Patterson, A. D., Cho, J.-Y., Krausz, K. W., & Gonzalez, F. J. (2011) · Hepatology · doi:10.1002/hep.24193 · Cited by 99
Self-citationMencarelli, A., Distrutti, E., Renga, B., D'Amore, C., Cipriani, S., Palladino, G., Donini, A., Ricci, P., & Fiorucci, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022978 · Cited by 97
Zollner, G., Wagner, M., Fickert, P., Geier, A., Fuchsbichler, A., Silbert, D., Gumhold, J., Zatloukal, K., Kaser, A., Tilg, H., et al. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00319.2004 · Cited by 97
Herrema, H., Meissner, M., van Dijk, T. H., Brufau, G., Boverhof, R., Oosterveer, M. H., Reijngoud, D.-J., Müller, M., Stellaard, F., Groen, A. K., et al. (2010) · Hepatology · doi:10.1002/hep.23408 · Cited by 96
Hansen, M., Scheltema, M. J., Sonne, D. P., Hansen, J. S., Sperling, M., Rehfeld, J. F., Holst, J. J., Vilsbøll, T., & Knop, F. K. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12648 · Cited by 96
Al-Dury, S., & Marschall, H.-U. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00931 · Cited by 95
Graffner, H., Gillberg, P. ‐., Rikner, L., & Marschall, H. ‐. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13457 · Cited by 94
Antidiabetogenic Action of Cholecystokinin-8 in Type 2 Diabetes
Ahren, B. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.1043 · Cited by 90
Lee, C. G., Kim, Y. W., Kim, E. H., Meng, Z., Huang, W., Hwang, S. J., & Kim, S. G. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.01.007 · Cited by 90
McCarthy, T. C., Li, X., & Sinal, C. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411520200 · Cited by 90
The Commensal Microbe V eillonella as a Marker for Response to an FGF19 Analog in NASH
Loomba, R., Ling, L., Dinh, D. M., DePaoli, A. M., Lieu, H. D., Harrison, S. A., & Sanyal, A. J. (2021) · Hepatology · doi:10.1002/hep.31523 · Cited by 88
Syndecan-1 Expression Is Regulated in an Isoform-specific Manner by the Farnesoid-X Receptor
Anisfeld, A. M., Kast-Woelbern, H. R., Meyer, M. E., Jones, S. A., Zhang, Y., Williams, K. J., Willson, T., & Edwards, P. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302505200 · Cited by 88
Purushotham, A., Xu, Q., Lu, J., Foley, J. F., Yan, X., Kim, D.-H., Kemper, J. K., & Li, X. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05988-11 · Cited by 87
Higher circulating bile acid concentrations in obese patients with type 2 diabetes
Vincent, R. P., Omar, S., Ghozlan, S., Taylor, D. R., Cross, G., Sherwood, R. A., Fandriks, L., Olbers, T., Werling, M., Alaghband-Zadeh, J., et al. (2013) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563212473450 · Cited by 84
The 'forgotten' bile acid sequestrants: is now a good time to remember?
Bays, H. E., & Goldberg, R. B. (2007) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31815a69fc · Cited by 83
Kawamoto, K., Horibe, I., & Uchida, K. (1989) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a122962 · Cited by 83
Rizzolo, D., Buckley, K., Kong, B., Zhan, L., Shen, J., Stofan, M., Brinker, A., Goedken, M., Buckley, B., & Guo, G. L. (2019) · Hepatology · doi:10.1002/hep.30612 · Cited by 83
Disorders of bile acid metabolism in cholesterol gallstone disease.
Berr, F., Pratschke, E., Fischer, S., & Paumgartner, G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115961 · Cited by 82
IL-17A Synergistically Enhances Bile Acid–Induced Inflammation during Obstructive Cholestasis
O'Brien, K. M., Allen, K. M., Rockwell, C. E., Towery, K., Luyendyk, J. P., & Copple, B. L. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.07.019 · Cited by 82
Chen, L., McNulty, J. A., Anderson, D., Liu, Y., Nystrom, C., Bullard, S., Collins, J. L., Handlon, A. L., Klein, R. R., Grimes, A. M., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.166892 · Cited by 80
Liver Injury in Patients With Cholestatic Liver Disease Treated With Obeticholic Acid
Eaton, J. E., Vuppalanchi, R., Reddy, R., Satapathy, S. K., Ali, B., & Kamath, P. S. (2020) · Hepatology · doi:10.1002/hep.31017 · Cited by 80
Sanyal, A. J., Ling, L., Beuers, U., DePaoli, A. M., Lieu, H. D., Harrison, S. A., & Hirschfield, G. M. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100255 · Cited by 79
Jones, S. A. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0887-1_11 · Cited by 78
Briere, D. A., Ruan, X., Cheng, C. C., Siesky, A. M., Fitch, T. E., Dominguez, C., Sanfeliciano, S. G., Montero, C., Suen, C. S., Xu, Y., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136873 · Cited by 78
Negative feedback regulation of bile acid metabolism: Impact on liver metabolism and diseases
Chiang, J. Y. L. (2015) · Hepatology · doi:10.1002/hep.27964 · Cited by 77
Self-citationMiyata, M., Sakaida, Y., Matsuzawa, H., Yoshinari, K., & Yamazoe, Y. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1885 · Cited by 77
Fuchs, C. D., Paumgartner, G., Mlitz, V., Kunczer, V., Halilbasic, E., Leditznig, N., Wahlström, A., Ståhlman, M., Thüringer, A., Kashofer, K., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314553 · Cited by 76
Hodge, R. J., Lin, J., Vasist Johnson, L. S., Gould, E. P., Bowers, G. D., Nunez, D. J., & on behalf of the SB‐756050 Project Team (2013) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.34 · Cited by 75
Pruritus in Chronic Cholestatic Liver Disease
Bunchorntavakul, C., & Reddy, K. R. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.03.010 · Cited by 75
Bisschop, P. H. L. T., Bandsma, R., Stellaard, F., ter Harmsel, A., Meijer, A. J., Sauerwein, H. P., Kuipers, F., & Romijn, J. A. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.4.570 · Cited by 75
Kulkarni, S. R., Soroka, C. J., Hagey, L. R., & Boyer, J. L. (2016) · Hepatology · doi:10.1002/hep.28826 · Cited by 75
Bile acid receptors and the kidney
Herman‐Edelstein, M., Weinstein, T., & Levi, M. (2017) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000374 · Cited by 75
Roth, J. D., Feigh, M., Veidal, S. S., Fensholdt, L. K., Rigbolt, K. T., Hansen, H. H., Chen, L. C., Petitjean, M., Friley, W., Vrang, N., et al. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i2.195 · Cited by 75
Role of farnesoid X receptor in inflammation and resolution
Shaik, F. B., Prasad, D. V. R., & Narala, V. R. (2014) · Inflammation Research · doi:10.1007/s00011-014-0780-y · Cited by 73
Carino, A., Biagioli, M., Marchianò, S., Fiorucci, C., Zampella, A., Monti, M. C., Scarpelli, P. T., Ricci, P., Distrutti, E., & Fiorucci, S. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.07.006 · Cited by 73
Miyata, M., Takamatsu, Y., Kuribayashi, H., & Yamazoe, Y. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.160093 · Cited by 72
Lithocholic Acid Is a Vitamin D Receptor Ligand That Acts Preferentially in the Ileum
Ishizawa, M., Akagi, D., & Makishima, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071975 · Cited by 72
Farnesoid X Receptor Induces GLUT4 Expression Through FXR Response Element in the GLUT4 Promoter
Shen, H., Zhang, Y., Ding, H., Wang, X., Chen, L., Jiang, H., & Shen, X. (2008) · Cellular Physiology and Biochemistry · doi:10.1159/000149779 · Cited by 69
Implication of intestinal VDR deficiency in inflammatory bowel disease
Kim, J. H., Yamaori, S., Tanabe, T., Johnson, C. H., Krausz, K. W., Kato, S., & Gonzalez, F. J. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.09.020 · Cited by 68
Bile Acid Replacement Therapy with Cholylsarcosine for Short-Bowel Syndrome
Heydorn, S. (1999) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655299750025769 · Cited by 68
Okushin, K., Tsutsumi, T., Enooku, K., Fujinaga, H., Kado, A., Shibahara, J., Fukayama, M., Moriya, K., Yotsuyanagi, H., & Koike, K. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1148-y · Cited by 68
Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers
Pencek, R., Marmon, T., Roth, J. D., Liberman, A., Hooshmand‐Rad, R., & Young, M. A. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12681 · Cited by 67
Hepatic NFAT signaling regulates the expression of inflammatory cytokines in cholestasis
Cai, S., Yu, D., Soroka, C. J., Wang, J., & Boyer, J. L. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.09.035 · Cited by 66
Carino, A., Graziosi, L., D’Amore, C., Cipriani, S., Marchianò, S., Marino, E., Zampella, A., Rende, M., Mosci, P., Distrutti, E., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10477 · Cited by 65
Give the Receptor a Brake: Slowing Gastric Emptying by GLP-1
Tong, J., & D’Alessio, D. (2014) · Diabetes · doi:10.2337/db13-1764 · Cited by 63
Li, Z., Lin, B., Lin, G., Wu, Y., Jie, Y., Li, X., Ko, B., Chong, Y., & Luo, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178580 · Cited by 63
Okamura, M., Shizu, R., Abe, T., Kodama, S., Hosaka, T., Sasaki, T., & Yoshinari, K. (2020) · Cells · doi:10.3390/cells9102296 · Cited by 63
Clinical Efficacy and Effectiveness of Ursodeoxycholic Acid in Cholestatic Liver Diseases
Festi, D., Montagnani, M., Azzaroli, F., Lodato, F., Mazzella, G., Roda, A., Biase, A. R. D., Roda, E., Simoni, P., & Colecchia, A. (2007) · Current Clinical Pharmacology · doi:10.2174/157488407780598171 · Cited by 62
Conjugated bile acid replacement therapy reduces urinary oxalate excretion in short bowel syndrome
Emmett, M., Guirl, M. J., Ana, C. A. S., Porter, J. L., Neimark, S., Hofmann, A. F., & Fordtran, J. S. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50012 · Cited by 61
Erichsen, T. J., Aehlen, A., Ehmer, U., Kalthoff, S., Manns, M. P., & Strassburg, C. P. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.01.010 · Cited by 61
Guo, C., Su, J., Li, Z., Xiao, R., Wen, J.-X., Li, Y., Zhang, M., Zhang, X., Yu, D. D., Huang, W., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5353 · Cited by 59
Garcinoic Acid Is a Natural and Selective Agonist of Pregnane X Receptor
Bartolini, D., Franco, F., Torquato, P., Marinelli, R., Cerra, B., Ronchetti, R., Schön, A., Fallarino, F., LUCA, A. D., Bellezza, G., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00012 · Cited by 58
Lithocholic acid induction of the FGF19 promoter in intestinal cells is mediated by PXR
Wistuba, W. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i31.4230 · Cited by 57
The bile salt export pump: molecular properties, function and regulation
Arrese, M. A., & Ananthanarayanan, M. (2004) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-004-1311-4 · Cited by 57
Vitamin D receptor agonists’ anti‐inflammatory properties
Vojinović, J. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12429 · Cited by 56
Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice
Fu, Z. D., & Klaassen, C. D. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.10.020 · Cited by 56
Ma, Y., & Liu, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038734 · Cited by 55
Marina, A. L., Utzschneider, K. M., Wright, L. A., Montgomery, B. K., Marcovina, S. M., & Kahn, S. E. (2012) · Diabetes Care · doi:10.2337/dc11-2050 · Cited by 55
Green, C. L., Mitchell, S. E., Derous, D., Wang, Y., Chen, L., Han, J.-D. J., Promislow, D. E. L., Lusseau, D., Douglas, A., & Speakman, J. R. (2017) · Aging Cell · doi:10.1111/acel.12570 · Cited by 54
Bile Acids, FXR, and Metabolic Effects of Bariatric Surgery
Noel, O. F., Still, C. D., Argyropoulos, G. A., Edwards, M. A., & Gerhard, G. S. (2016) · Journal of Obesity · doi:10.1155/2016/4390254 · Cited by 53
Bile Salt Hydrolase Activities: A Novel Target to Screen Anti-Giardia Lactobacilli?
Allain, T., Chaouch, S., Thomas, M., Travers, M.-A., Valle, I., Langella, P., Grellier, P., Polack, B., Florent, I., & Bermúdez-Humarán, L. G. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00089 · Cited by 53
Bile Acids in Cholestasis and its Treatment
Arab, J. P., Cabrera, D., & Arrese, M. A. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0010.5497 · Cited by 52
John, B. V., Schwartz, K., Levy, C., Dahman, B., Deng, Y., Martin, P., Taddei, T. H., & Kaplan, D. E. (2021) · Hepatology Communications · doi:10.1002/hep4.1720 · Cited by 51
Isolation and Characterization of Bile Acid 7‐Dehydroxylating Bacteria from Human Feces
Takamine, F., & Imamura, T. (1995) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1995.tb02162.x · Cited by 50
Leikin-Frenkel, A. I., Gonen, A., Shaish, A., Goldiner, I., Leikin-Gobbi, D., Konikoff, F. M., Harats, D., & Gilat, T. (2010) · Archives of Medical Research · doi:10.1016/j.arcmed.2010.09.001 · Cited by 50
Tiessen, R. G., Kennedy, C. A., Keller, B. T., Levin, N., Acevedo, L., Gedulin, B., van Vliet, A. A., Dorenbaum, A., & Palmer, M. (2018) · BMC Gastroenterology · doi:10.1186/s12876-017-0736-0 · Cited by 50
Mythen, S. M., Devendran, S., Méndez–García, C., Cann, I., & Ridlon, J. M. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.02475-17 · Cited by 48
Cariello, M., Peres, C. M., Zerlotin, R., Porru, E., Sabbà, C., Roda, A., & Moschetta, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-11549-7 · Cited by 47
Alasmael, N., Mohan, R., Meira, L. B., Swales, K. E., & Plant, N. J. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.031 · Cited by 46
Hoekstra, M., Lammers, B., Out, R., Li, Z., Eck, M. V., & van Berkel, T. J. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800131d · Cited by 44
Coppola, C. P., Gosche, J. R., Arrese, M. A., Ancowitz, B. A., MADSEN, J., Vanderhoof, J. A., & Shneider, B. L. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70088-5 · Cited by 43
Noh, K., Kim, Y. M., Kim, Y. W., & Kim, S. G. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.038414 · Cited by 43
Deoxycholic acid stimulates migration in colon cancer cells
Milović, V., Teller, I. C., Murphy, G. M., Caspary, W. F., & Stein, J. M. (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200108000-00012 · Cited by 41
Hudson, G., Flannigan, K. L., Venu, V. K. P., Alston, L. A., Sandall, C. F., MacDonald, J. A., Muruve, D. A., Chang, T. K. H., Mani, S., & Hirota, S. A. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.255679 · Cited by 39
Planar bile acids in health and disease
Shiffka, S. J., Kane, M. A., & Swaan, P. W. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.08.019 · Cited by 38
Hydrolysis of bile acid conjugates by Clostridium bifermentans
Archer, R. H., Chong, R., & Maddox, I. S. (1982) · Applied Microbiology and Biotechnology · doi:10.1007/bf00508002 · Cited by 37
Steroidal Scaffolds as FXR and GPBAR1 Ligands: From Chemistry to Therapeutical Application
Sepe, V., Distrutti, E., Limongelli, V., Fiorucci, S., & Zampella, A. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.54 · Cited by 37
Fecal bile acid excretion profile in gallstone patients.
Mamianetti, A., Garrido, D., Carducci, C. N., & Vescina, M. C. (1999) · PubMed · Cited by 36
Baijal, P. K., Fitzpatrick, D., & Bird, R. P. (1998) · Nutrition and Cancer · doi:10.1080/01635589809514685 · Cited by 36
Eyssen, H., Eldere, J. V., Parmentier, G. G., Huijghebaert, S., & Mertens, J. (1985) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(85)90176-1 · Cited by 36
Cole, A. J., Teigen, L. M., Jahansouz, C., Earthman, C. P., & Sibley, S. D. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0171-x · Cited by 35
Conjugated Bile Acid Replacement Therapy in Short Bowel Syndrome Patients with a Residual Colon
Kapral, C., Wewalka, F., Praxmarer, V., Lenz, K., & Hofmann, A. F. (2004) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2004-813059 · Cited by 35
A highly active bile salt hydrolase from Enterococcus faecalis shows positive cooperative kinetics
Chand, D., Ramasamy, S., & Suresh, C. G. (2015) · Process Biochemistry · doi:10.1016/j.procbio.2015.12.006 · Cited by 35
Intestinal microbiota drives cholestasis-induced specific hepatic gene expression patterns
Juanola, O., Hassan, M., Kumar, P., Yılmaz, B., Keller, I., Simillion, C., Engelmann, C., Tacke, F., Dufour, J., Gottardi, A. D., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1911534 · Cited by 35
Zambad, S. P., Tuli, D., Matur, A., Ghalsasi, S., Chaudhary, A., Deshpande, S., Gupta, R., Chauthaiwale, V. M., & Dutt, C. (2013) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s50209 · Cited by 34
Acute caloric restriction counteracts hepatic bile acid and cholesterol deficiency in morbid obesity
Straniero, S., Rosqvist, F., Edholm, D., Ahlström, H. K., Kullberg, J., Sundbom, M., Risérus, U., & Rudling, M. J. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12599 · Cited by 34
The Microbiome in Autoimmune Liver Diseases: Metagenomic and Metabolomic Changes
Zheng, Y., Ran, Y., Zhang, H., Wang, B., & Zhou, L. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.715852 · Cited by 32
Goldiner, I., van der Velde, A. E., Vandenberghe, K., van Wijland, M. J. A., Halpern, Z., Gilat, T., Konikoff, F. M., Veldman, R. J., & Groen, A. K. (2006) · Biochemical Journal · doi:10.1042/bj20051694 · Cited by 31
Antioxidant Drug Tempol Promotes Functional Metabolic Changes in the Gut Microbiota
Cai, J., Zhang, L., Jones, R. A., Correll, J. B., Hatzakis, E., Smith, P. B. W., Gonzalez, F. J., & Patterson, A. D. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00957 · Cited by 31
Self-citationLei, S., Huang, F., Zhao, A., Chen, T., Chen, W., Xie, G., Zheng, X., Zhang, Y., Yu, H., Zhang, P., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700055r · Cited by 30
Jiang, Y., Jin, J., Iakova, P. A., Hernandez, J. C., Jawanmardi, N., Sullivan, E. M., Guo, G. L., Timchenko, N. A., & Darlington, G. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.08.003 · Cited by 29
Marschall, H., Oppermann, U. C. I., Svensson, S., Nordling, E., Persson, B., Höög, J., & Jörnvall, H. (2000) · Hepatology · doi:10.1053/he.2000.5720 · Cited by 29
Xie, Y., Blanc, V., Kerr, T. A., Kennedy, S., Luo, J., Newberry, E. P., & Davidson, N. O. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.010173 · Cited by 28
Atypical Mechanism of Glucose Modulation by Colesevelam in Patients with Type 2 Diabetes
Nwose, O. M., & Jones, M. R. (2013) · Clinical Medicine Insights: Endocrinology and Diabetes · doi:10.4137/cmed.s12590 · Cited by 28
Hofmann, A. F. (2010) · Hepatology · doi:10.1002/hep.24100 · Cited by 28
Role of bile acid sequestrants in the treatment of type 2 diabetes
Takebayashi, K., Aso, Y., & Inukai, T. (2010) · World Journal of Diabetes · doi:10.4239/wjd.v1.i5.146 · Cited by 26
Sakamoto, S. X., Kusuhara, H., Miyata, K., Shimaoka, H., Kanazu, T., Matsuo, Y., Nomura, K., Okamura, N., Hara, S., Horie, K., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.116426 · Cited by 24
Konikoff, F. M., & Gilat, T. (2005) · Current Drug Targets - Immune Endocrine & Metabolic Disorders · doi:10.2174/1568008054064904 · Cited by 23
Mayo, M. J., Pockros, P., Jones, D. E., Bowlus, C. L., Levy, C., Patanwala, I., Bacon, B. R., Luketic, V. A., Vuppalanchi, R., MEDENDORP, S. V., et al. (2016) · Journal of Hepatology · doi:10.1016/s0168-8278(16)00146-x · Cited by 23
Wang, J., Dai, S., Guo, Y., Xie, W., & Zhai, Y. (2014) · EXCLI journal · doi:10.17877/de290r-6707 · Cited by 22
Lionarons, D. A., Heger, M., van Golen, R. F., Alles, L. K., van der Mark, V. A., Kloek, J. J., de Waart, D. R., Marsman, H. A., Rusch, H., Verheij, J., et al. (2016) · Scientific Reports · doi:10.1038/srep31829 · Cited by 20
Study of human isoursodeoxycholic acid metabolism
Marschall, H., Roeb, E., Yildiz, Y., Busch, N., Nguyen, H., Purucker, E. A., Thomas, H. G., & Matern, S. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80254-1 · Cited by 19
Navigation in bile acid chemical space: discovery of novel FXR and GPBAR1 ligands
Finamore, C., Festa, C., Renga, B., Sepe, V., Carino, A., Masullo, D., Biagioli, M., Marchianò, S., Capolupo, A., Monti, M. C., et al. (2016) · Scientific Reports · doi:10.1038/srep29320 · Cited by 19
Proceedings of the 2017 ASPEN Research Workshop—Gastric Bypass: Role of the Gut
Jain, A. K., le Roux, C. W., Puri, P., Tavakkoli, A., Gletsu-Miller, N. A., Laferrère, B., Kellermayer, R., DiBaise, J. K., Martindale, R. G., & Wolfe, B. M. (2018) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1121 · Cited by 19
TAZUKE, Y., MATSUDA, K., ADACHI, K., & TSUKADA, Y. (1998) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.62.1739 · Cited by 18
Epimerization, oxidation and reduction of bile acids by Eubacterium lentum
Edenharder, R., & Mielek, K. (1984) · Systematic and Applied Microbiology · doi:10.1016/s0723-2020(84)80031-4 · Cited by 18
Teske, K. A., Bogart, J. W., Sanchez, L. M., Yu, O. B., Preston, J., Cook, J. M., Silvaggi, N. R., Bikle, D. D., & Arnold, L. A. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.01.002 · Cited by 17
Novel strategies and therapeutic options for the management of primary biliary cholangitis
Khanna, A., & Jones, D. E. (2017) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x17728669 · Cited by 16
Lithocholic Acid Amides as Potent Vitamin D Receptor Agonists
Yoshihara, A., Kawasaki, H., Masuno, H., Takada, K., Numoto, N., Ito, N., Hirata, N., Kanda, Y., Ishizawa, M., Makishima, M., et al. (2022) · Biomolecules · doi:10.3390/biom12010130 · Cited by 16
Zackular, J. P., Moore, J. L., Jordan, A., Juttukonda, L. J., Noto, M. J., Nicholson, M. R., Crews, J. D., Semler, M. W., Zhang, Y., Ware, L. B., et al. (2016) · Nature Medicine · doi:10.1038/nm1216-1502d · Cited by 15
Robben, J., Janssen, G., Merckx, R., & Eyssen, H. (1989) · Applied and Environmental Microbiology · doi:10.1128/aem.55.11.2954-2959.1989 · Cited by 13
A variant of FGF19 for treatment of disorders of cholestasis and bile acid metabolism.
Walters, J. R. F., & Appleby, R. (2015) · PubMed · doi:10.3978/j.issn.2305-5839.2015.03.38 · Cited by 13
Guan, L., & Miao, P. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173616 · Cited by 13
Clinical inquiry: what risk factors contribute to C difficile diarrhea?
Fashner, J., Garcia, M., Ribble, L., & Crowell, K. (2011) · PubMed · Cited by 12
Deoxycholic Acid Methyl Ester — a Novel Bacterial Metabolite of Cholic Acid
Edenharder, R., & Hammann, R. (1985) · Systematic and Applied Microbiology · doi:10.1016/s0723-2020(85)80005-9 · Cited by 11
Multiplatform Physiologic and Metabolic Phenotyping Reveals Microbial Toxicity
Cai, J., Nichols, R. G., Koo, I., Kalikow, Z. A., Zhang, L., Tian, Y., Zhang, J., Smith, P. B. W., & Patterson, A. D. (2018) · mSystems · doi:10.1128/msystems.00123-18 · Cited by 11
Self-citationShyng, S. (2017) · Diabetes · doi:10.2337/dbi16-0066 · Cited by 9
Biological evaluation and synthesis of calcitroic acid
Yu, O. B., Webb, D. A., DiMilo, E., Mutchie, T. R., Teske, K. A., Chen, T., Lin, W., Peluso‐Iltis, C., Rochel, N., Helmstädter, M., et al. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105310 · Cited by 6
Cited by
Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
Shen, Y., Fan, N., Ma, S., Cheng, X., Yang, X., & Wang, G. (2025) · MedComm · doi:10.1002/mco2.70168 · Cited by 301
The changing metabolic landscape of bile acids – keys to metabolism and immune regulation
Mohanty, I., Allaband, C., Mannochio-Russo, H., El Abiead, Y., Hagey, L. R., Knight, R., & Dorrestein, P. C. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00914-3 · Cited by 218
Jakobsson, J. E., Menezes, J., Krock, E., Hunt, M. A., Carlsson, H., Vaivade, A., Emami Khoonsari, P., Agalave, N. M., Sandström, A., Kadetoff, D., et al. (2025) · The Journal of Pain · doi:10.1016/j.jpain.2025.105331 · Cited by 9
Odoribacter laneus protects intestinal barrier by bile acid-FXR axis in acute pancreatitis
Gu, R., Li, J., Qi, J., Sun, R., Wu, H., & Jin, B. (2026) · AMB Express · doi:10.1186/s13568-026-02071-z · Cited by 2
Agolino, G., Cristofolini, M., Ronsivalle, M. A., Cattivelli, A., Tagliazucchi, D., Caggia, C., Solieri, L., & Randazzo, C. L. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10810-0 · Cited by 1
Metadata
- Authors
- Cai, J., Rimal, B., Jiang, C., Chiang, J. Y. L., & Patterson, A. D.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2022-09
- Volume
- 237
- Pages
- 108238
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W4283766901
- Cited by
- 497
- References
- 399
- FWCI
- 23.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.